(Q38150910)

29 August 2017

Advances in adenovirus-mediated p53 cancer gene therapy (English)

1 reference

29 August 2017

0 references

1 reference

1 reference

Hiroshi Tazawa

1

0 references

Shunsuke Kagawa

object named as

Shunsuke Kagawa

series ordinal

2

0 references

author name string

Toshiyoshi Fujiwara

series ordinal

3

1 reference

PubMed ID

24107178

29 August 2017

language of work or name

English

0 references

publication date

1 November 2013

1 reference

Expert Opinion on Biological Therapy

29 August 2017

1 reference

29 August 2017

13

1 reference

29 August 2017

11

1 reference

29 August 2017

1569-1583

1 reference

Gene therapy for cancer: what have we done and where are we going?

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

TP53 mutations in human cancers: origins, consequences, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

p53 family members and chemoresistance in cancer: what we know and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p53 gene therapy for human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-based p53 gene therapy in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Preclinical study of adenoviral p53 gene therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

INGN 201 (Advexin): adenoviral p53 gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p53 gene therapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

21 January 2018

p53-based cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

TP53 mutations in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Head and neck cancer: response to p53-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

21 January 2018

Oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Rethinking ovarian cancer: recommendations for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

p53 gene mutations and protein accumulation in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

New strategies in muscle-invasive bladder cancer: on the road to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Telomerase-specific replication-selective virotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

Restoration of p53 function leads to tumour regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.845662

10.1517/14712598.2013.845662

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24107178